ASP Isotopes Files 8-K: Regulation FD Disclosure, Press Release Included

TL;DR

**ASP Isotopes just dropped an 8-K with a press release, signaling important news is out.**

AI Summary

ASP Isotopes Inc. filed an 8-K on March 24, 2026, under Item 7.01, Regulation FD Disclosure, which typically means they are sharing important, non-public information to ensure all investors receive it simultaneously. This filing includes a press release (EX-99.1) that likely contains the specific details of this disclosure. For investors, this matters because it signals that the company has news significant enough to warrant immediate public dissemination, which could impact the stock price depending on the nature of the announcement.

Why It Matters

This filing indicates ASP Isotopes Inc. has released material non-public information, likely via the included press release, which could significantly influence investor perception and stock valuation.

Risk Assessment

Risk Level: medium — The risk level is medium because the specific content of the press release is not detailed in the filing summary, so the impact on the stock is currently unknown.

Analyst Insight

A smart investor would immediately review the attached press release (EX-99.1) to understand the specific details of the Regulation FD disclosure and assess its potential impact on ASP Isotopes Inc.'s future performance and stock price.

Key Players & Entities

• ASP Isotopes Inc. (company) — the filer of the 8-K
• 0001921865 (company) — CIK of ASP Isotopes Inc.
• 2026-03-24 (date) — filing and acceptance date of the 8-K

FAQ

Key Financial Figures

• $0.01 — ich registered Common Stock, par value $0.01 ASPI The Nasdaq Stock Market LLC

Filing Documents

• aspi_8k.htm (8-K) — 26KB
• aspi_ex991.htm (EX-99.1) — 12KB
• 0001477932-26-001545.txt ( ) — 158KB
• aspi-20260324.xsd (EX-101.SCH) — 5KB
• aspi-20260324_lab.xml (EX-101.LAB) — 15KB
• aspi-20260324_cal.xml (EX-101.CAL) — 1KB
• aspi-20260324_pre.xml (EX-101.PRE) — 9KB
• aspi-20260324_def.xml (EX-101.DEF) — 2KB
• aspi_8k_htm.xml (XML) — 3KB

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On March 24, 2026, ASP Isotopes Inc. (the "Company") issued a press release regarding a strategic collaboration between a UK subsidiary of Quantum Leap Energy LLC and the University of Bristol for the design of a state-of-the-art lithium laser research facility in the UK, which is attached hereto as Exhibit 99.1 and is incorporated by reference herein (the "Press Release"). The information in this Item 7.01 and in the Press Release shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended, and shall not be incorporated by reference into any filing with the U.S. Securities and Exchange Commission, whether made by the Company before or after the date hereof, regardless of any general incorporation language in such filing. The Press Release includes "safe harbor" language pursuant to the Private Securities Litigation Reform Act of 1995, as amended, indicating that certain statements contained therein are "forward-looking" rather than historical.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release dated March 24, 2026. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ASP ISOTOPES INC. Date: March 24, 2026 By: /s/ Donald G. Ainscow Name: Donald G. Ainscow Title: Executive Vice President, General Counsel and Secretary 3

View Full Filing

View this 8-K filing on SEC EDGAR